Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Genetic Analysis

1.16

 

NOK

 

-7.2 %

Less than 1K followers

GEAN

Spotlight Stock Market

Medical Equipment & Services

Health Care

Overview
Ownership
Investor consensus
Compare
-7.2%
-18.31%
+36.47%
+127.45%
+118.87%
+75.76%
-67.51%
-
-89.16%

Genetic Analysis operates in medical technology. The company conducts research and development in the field of diagnostics, with the main focus on the human microbiome. The technology is based on the company's research platform and the products are used, for example, for testing and analysis of bacteria and other viruses. The largest operations are in the Nordic market.

Read more
Market cap
74.56M NOK
Turnover
31.36K NOK
Revenue
15.89M
EBIT %
-89.49 %
P/E
-
Dividend yield-%
-
Financial calendar
27/8
2025

Interim report Q2'25

27/11
2025

Interim report Q3'25

25/2
2026

Annual report '25

All
Press releases
3rd party
ShowingAll content types
Press release5/28/2025, 6:20 AM

Analyst Group: Analyst Group Comment on Genetic Analysis Q1-report Report 2025

Genetic Analysis
Regulatory press release5/27/2025, 1:40 PM

Genetic Analysis AS: Correction: Publication of Q1 report January - March 2025

Genetic Analysis
Regulatory press release5/27/2025, 6:56 AM

Genetic Analysis AS: Genetic Analysis announces details of Subsequent Offering following directed issue

Genetic Analysis

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release5/27/2025, 6:00 AM

Genetic Analysis AS: Publication of Q1 report January - March 2025

Genetic Analysis
Regulatory press release5/20/2025, 7:05 AM

Genetic Analysis AS: Mandatory notification of trade

Genetic Analysis
Regulatory press release5/20/2025, 7:03 AM

Minutes from the Annual General Meeting 2024 in Genetic Analysis AS

Genetic Analysis
Third party research5/5/2025, 1:22 PM

Analyst Group Comment on Genetic Analysis Directed Share Issue of NOK 12.8m

On May 5th, Genetic Analysis AS (“Genetic Analysis” or the “Company”) announced a placement of a directed issue of NOK 12.8m before transactions related costs of NOK 0.6m, which is conditional on approval from the annual general meeting on May 19th. ...

Genetic Analysis
Press release5/5/2025, 12:00 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Directed Share Issue of NOK 12.8m

Genetic Analysis
Regulatory press release5/5/2025, 7:45 AM

Genetic Analysis AS: Correction: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million

Genetic Analysis
Regulatory press release5/5/2025, 6:05 AM

Genetic Analysis AS: Notice of annual general meeting

Genetic Analysis
Regulatory press release5/5/2025, 6:02 AM

Genetic Analysis AS: Genetic Analysis announces proposed changes to the Board

Genetic Analysis
Regulatory press release5/5/2025, 6:00 AM

Genetic Analysis AS: Genetic Analysis announces placement of a directed share issue of NOK 12.8 million

Genetic Analysis
Regulatory press release5/2/2025, 7:00 AM

Genetic Analysis AS publishes Annual Report 2024

Genetic Analysis
Third party research4/23/2025, 5:22 AM

Analyst Group Comment on Genetic Analysis Launch of a Consumer Test to the Chinese Market

On April 22nd, Genetic Analysis AS (“Genetic Analysis” or the “Company”) announced that the Company are launching a microbiome test for the Consumer Health (D2C) market in China in collaboration with Thalys Medical Technology Group Corporation (“Thalys...

Genetic Analysis
Press release4/22/2025, 2:08 PM

Analyst Group: Analyst Group Comment on Genetic Analysis Launch of a Consumer Test to the Chinese Market

Genetic Analysis
Regulatory press release4/22/2025, 6:00 AM

Genetic Analysis AS and Thalys Medical Technology Group are pleased to announce the launch of a microbiome test to the Chinese Consumer Health market

Genetic Analysis
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team